1351-0711 < 1351-5101 < 1353-5226

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 129.
[0-50] [0 - 20][0 - 50][50-70]

Ident.	Authors (with country if any)	Title
000001 (2011)	D. S. Goldstein ; P. Sullivan ; C. Holmes ; I. J. Kopin ; M. J. Basile ; D. C. Mash	Catechols in post‐mortem brain of patients with Parkinson disease
000003 (2009)	H. Sawada ; T. Oeda ; K. Yamamoto ; N. Kitagawa ; E. Mizuta ; R. Hosokawa ; M. Ohba ; R. Nishio ; K. Yamakawa ; H. Takeuchi ; S. Shimohama ; R. Takahashi ; T. Kawamura	Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease
000070 (2008)	A. H. V. Schapira	Progress in neuroprotection in Parkinson’s disease
000086 (2011)	C. Becker ; S. S. Jick ; C. R. Meier	NSAID use and risk of Parkinson disease: a population‐based case‐control study
000139 (1999)	Franz Gerstenbrand ; Elisabeth Karamat	Adolf Hitler's Parkinson's disease and an attempt to analyse his personality structure
000200 (2009)	A. H. Schapira ; Y. Agid ; P. Barone ; P. Jenner ; M. R. Lemke ; W. Poewe ; O. Rascol ; H. Reichmann ; E. Tolosa	Perspectives on recent advances in the understanding and treatment of Parkinson’s disease
000211 (2010)	S. Costello ; Y. Bordelon ; J. Bronstein ; B. Ritz	Familial associations of Alzheimer disease and essential tremor with Parkinson disease
000255 (2011)	C. Huang ; Y. Wu-Chou ; S. Lai ; H. Chang ; T. Yeh ; Y. Weng ; R. Chen ; Y. Huang ; C. Lu	Contribution of glucocerebrosidase mutation in a large cohort of sporadic Parkinson’s disease in Taiwan
000260 (1994)	A. Röhl ; H. Friedrich ; G. Ulm ; P. Vieregge	The relevance of clinical subtypes for disease course, family history and epidemiological variables in Parkinson's disease
000278 (2010)	P. Barone	Neurotransmission in Parkinson’s disease: beyond dopamine
000308 (2007)	G. Linazasoro	Classical Parkinson disease versus Parkinson complex – Reflections against staging and in favour of heterogeneity
000320 (2006)	D. Gosal ; O. A. Ross ; M. Toft	Parkinson's disease: the genetics of a heterogeneous disorder
000321 (2002)	K. Marek ; D. Jennings ; J. Seibyl	Do dopamine agonists or levodopa modify Parkinson's disease progression?
000347 (2011)	C. Becker ; G. P. Brobert ; S. Johansson ; S. S. Jick ; C. R. Meier	Risk of incident depression in patients with Parkinson disease in the UK
000403 (2006)	M. Horstink ; E. Tolosa ; U. Bonuccelli ; G. Deuschl ; A. Friedman ; P. Kanovsky ; J. P. Larsen ; A. Lees ; W. Oertel ; W. Poewe ; O. Rascol ; C. Sampaio	Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society–European Section. Part I: early (uncomplicated) Parkinson's disease
000404 (2011)	O. Rascol	Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged‐release
000412 (2011)	A. H. V. Schapira	Challenges to the development of disease‐modifying therapies in Parkinson’s disease
000445 (2010)	P. O. Valko ; D. Waldvogel ; M. Weller ; C. L. Bassetti ; U. Held ; C. R. Baumann	Fatigue and excessive daytime sleepiness in idiopathic Parkinson’s disease differently correlate with motor symptoms, depression and dopaminergic treatment
000553 (2011)	Y. Oh ; J. Kim ; S. Chung ; I. Song ; Y. Kim ; Y. Kim ; K. Lee	Color vision in Parkinson’s disease and essential tremor
000576 (2010)	C. Rodriguez-Blazquez ; M. J. Forjaz ; B. Frades-Payo ; J. De Pedro-Cuesta ; P. Martinez-Martin	Independent validation of the scales for outcomes in Parkinson’s disease‐autonomic (SCOPA‐AUT)
000643 (2010)	E. L. Johnsen ; N. Sunde ; P. H. Mogensen ; K. Stergaard	MRI verified STN stimulation site – gait improvement and clinical outcome
000670 (2010)	C. A. Guevara ; C. R. Blain ; D. Stahl ; D. J. Lythgoe ; P. N. Leigh ; G. J. Barker	Quantitative magnetic resonance spectroscopic imaging in Parkinson’s disease, progressive supranuclear palsy and multiple system atrophy
000684 (2010)	L. Samaranch ; E. Lorenzo ; M. A. Pastor ; M. Riverol ; M. R. Luquin ; M. C. Rodríguez-Oroz ; J. A. Obeso ; P. Pastor	Analysis of the GIGYF2 gene in familial and sporadic Parkinson disease in the Spanish population
000732 (2011)	C. Wider ; C. Vilari O-Güell ; M. G. Heckman ; B. Jasinska-Myga ; A. I. Ortolaza-Soto ; N. N. Diehl ; J. E. Crook ; S. A. Cobb ; J. A. Bacon ; J. O. Aasly ; J. M. Gibson ; T. Lynch ; R. J. Uitti ; Z. K. Wszolek ; M. J. Farrer ; O. A. Ross	SNCA, MAPT, and GSK3B in Parkinson disease: a gene–gene interaction study
000750 (2006)	M. Horstink ; E. Tolosa ; U. Bonuccelli ; G. Deuschl ; A. Friedman ; P. Kanovsky ; J. P. Larsen ; A. Lees ; W. Oertel ; W. Poewe ; O. Rascol ; C. Sampaio	Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society‐European Section (MDS‐ES). Part II: late (complicated) Parkinson's disease
000757 (2008)	J. C. Möller ; K. M. Eggert ; M. Unger ; P. Odin ; K. R. Chaudhuri ; W. H. Oertel	Clinical risk–benefit assessment of dopamine agonists
000783 (2011)	Y. Baba ; M. Higuchi ; K. Fukuyama ; H. Abe ; Y. Uehara ; T. Inoue ; T. Yamada	Effect of chronic kidney disease on excessive daytime sleepiness in Parkinson disease
000818 (2008)	W. Poewe	Non‐motor symptoms in Parkinson’s disease
000844 (2010)	C. Tai ; R. Wu ; C. Lin ; M. Pan ; Y. Chen ; H. Liu ; H. Lu ; C. Tsai ; S. Tseng	Deep brain stimulation therapy for Parkinson’s disease using frameless stereotaxy: comparison with frame‐based surgery
000881 (2008)	R. Cilia ; G. Marotta ; A. Landi ; I. U. Isaias ; F. Vergani ; R. Benti ; E. Sganzerla ; P. Gerundini ; G. Pezzoli ; A. Antonini	Cerebral activity modulation by extradural motor cortex stimulation in Parkinson's disease: a perfusion SPECT study
000904 (2009)	T. D. H Lbig ; W. Tse ; P. G. Frisina ; B. R. Baker ; E. Hollander ; H. Shapiro ; M. Tagliati ; W. C. Koller ; C. W. Olanow	Subthalamic deep brain stimulation and impulse control in Parkinson’s disease
000913 (2011)	Y. J. Zhao ; L. C. S. Tan ; S. C. Li ; W. L. Au ; S. H. Seah ; P. N. Lau ; N. Luo ; H. L. Wee	Economic burden of Parkinson’s disease in Singapore
000933 (2008)	G. Linazasoro ; J. Kulisevsky ; B. Hernández	Should levodopa dose be reduced when switched to stalevo?
000944 (2010)	H. Reichmann ; W. H. Jost	Efficacy and tolerability of rasagiline in daily clinical use – a post‐marketing observational study in patients with Parkinson’s disease
000948 (2011)	F. Stocchi ; J. M. Rabey	Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson’s disease
000985 (2004)	W. Heiss ; R. Hilker	The sensitivity of 18‐fluorodopa positron emission tomography and magnetic resonance imaging in Parkinson's disease
000996 (2008)	N. I. Bohnen ; S. A. Studenski ; G. M. Constantine ; R. Y. Moore	Diagnostic performance of clinical motor and non‐motor tests of Parkinson disease: a matched case–control study
000999 (2010)	C. Rossi ; D. Frosini ; D. Volterrani ; P. De Feo ; E. Unti ; V. Nicoletti ; L. Kiferle ; U. Bonuccelli ; R. Ceravolo	Differences in nigro‐striatal impairment in clinical variants of early Parkinson’s disease: evidence from a FP‐CIT SPECT study
000A07 (2010)	F. Hu ; J. Xi ; J. Guo ; L. Yu ; L. Liu ; X. He ; Z. Liu ; X. Zou ; Y. Xu	Association of the glucocerebrosidase N370S allele with Parkinson’s disease in two separate Chinese Han populations of mainland China
000B23 (2009)	E. Elgh ; M. Domellöf ; J. Linder ; M. Edström ; H. Stenlund ; L. Forsgren	Cognitive function in early Parkinson’s disease: a population‐based study
000B58 (2005)	M. Péchevis ; C. E. Clarke ; P. Vieregge ; B. Khoshnood ; C. Deschaseaux-Voinet ; G. Berdeaux ; M. Ziegler	Effects of dyskinesias in Parkinson's disease on quality of life and health‐related costs: a prospective European study
000B60 (2010)	P. Borghammer ; K. Stergaard ; P. Cumming ; A. Gjedde ; A. Rodell ; N. Hall ; M. M. Chakravarty	A deformation‐based morphometry study of patients with early‐stage Parkinson’s disease
000B78 (2009)	A. H. V. Schapira ; M. Emre ; P. Jenner ; W. Poewe	Levodopa in the treatment of Parkinson’s disease
000C29 (2009)	M. M. Lewis ; A. B. Smith ; M. Styner ; H. Gu ; R. Poole ; H. Zhu ; Y. Li ; X. Barbero ; S. Gouttard ; M. J. Mckeown ; R. B. Mailman ; X. Huang	Asymmetrical lateral ventricular enlargement in Parkinson’s disease
000D09 (2005)	D. Kaynak ; G. Kiziltan ; H. Kaynak ; G. Benbir ; O. Uysal	Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment
000E80 (2010)	Y. Winter ; M. Balzer-Geldsetzer ; A. Spottke ; J. P. Reese ; E. Baum ; J. Klotsche ; J. Rieke ; A. Simonow ; K. Eggert ; W. H. Oertel ; R. Dodel	Longitudinal study of the socioeconomic burden of Parkinson’s disease in Germany
000E85 (2008)	M. Steiger	Constant dopaminergic stimulation by transdermal delivery of dopaminergic drugs: a new treatment paradigm in Parkinson's disease
000E91 (2011)	R. Ceravolo ; L. Brusa ; S. Galati ; D. Volterrani ; A. Peppe ; G. Siciliano ; M. Pierantozzi ; V. Moschella ; U. Bonuccelli ; P. Stanzione ; A. Stefani	Low frequency stimulation of the nucleus tegmenti pedunculopontini increases cortical metabolism in Parkinsonian patients
000F03 (2008)	J. Kulisevsky ; J. Pagonabarraga ; B. Pascual-Sedano ; A. Gironell ; C. García-Sánchez ; M. Martínez-Corral	Motor changes during sertraline treatment in depressed patients with Parkinson’s disease
000F09 (2009)	H. Nissinen ; M. Kuoppam Ki ; M. Leinonen ; A. H. Schapira	Early versus delayed initiation of entacapone in levodopa‐treated patients with Parkinson’s disease: a long‐term, retrospective analysis
000F10 (2009)	F. R. Guerini ; E. Beghi ; G. Riboldazzi ; R. Zangaglia ; C. Pianezzola ; G. Bono ; C. Casali ; C. Di Lorenzo ; C. Agliardi ; G. Nappi ; M. Clerici ; E. Martignoni	BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson’s disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/ISSN.i -k "1351-5101" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/ISSN.i  \
                -Sk "1351-5101" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    ISSN.i
   |clé=    1351-5101
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024